CURRENT PATTERNS OF FIXED AND FREE LABA/ICS COMBINATION USAGE IN ASTHMA SHI PATIENTS IN GERMANY

被引：0
|
作者：
Bonthapally, V [1 ]
Wolbring, F. [2 ]
Sindern, J. [2 ]
Mehnert, A. [2 ]
机构：
[1] Univ Louisiana, Monroe, LA USA
[2] Janssen Cilag GmbH, Neuss, NRW, Germany
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A128 / A128
页数：1
相关论文
共 50 条
  • [41] Evaluation of ICS/LABA combination therapy on respiratory function in patients with asthma: Open-label, randomized, cross-over trial.
    Ohbayashi, Hiroyuki
    Kudo, Sahori
    Ariga, Mitsue
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [42] Clinical outcomes of adding xanthines to ICS and LABA combination in patients with chronic obstructive pulmonary disease
    Wang, Yueh-Hsin
    Lin, Hung-Wei
    Chien, Jung-Yien
    Lin, Fang-Ju
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 409 - 409
  • [43] Do we really target the receptors? Deposition and co-deposition of ICS-LABA fixed combination drugs
    Farkas, Arpad
    Horvath, Alpar
    Tomisa, Gabor
    Kovacs, Tamas
    Bocskei, Renata Marietta
    Kis, Erika
    Varga, Janos
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 174
  • [44] Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study
    Monteagudo, Monica
    Nunez, Alexa
    Barrecheguren, Miriam
    Miravitlles, Marc
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (10): : 699 - 707
  • [45] Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement
    Laitano, Rossella
    Calzetta, Luigino
    Matino, Matteo
    Pistocchini, Elena
    Rogliani, Paola
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (08) : 1071 - 1081
  • [46] THE COST-EFFECTIVENESS OF STEP DOWN FROM HIGH DOSE ICS/LABA COMBINATION THERAPY IN ASTHMA IN THE UK SETTING
    Paggiaro, P.
    Buseghin, G.
    Nicolini, G.
    Patel, S.
    Iannazzo, S.
    Zaniolo, O.
    Papi, A.
    VALUE IN HEALTH, 2011, 14 (07) : A493 - A494
  • [47] TRIPLE THERAPY (ICS/LABA/LAMA) IN PATIENTS WITH UNCONTROLLED ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Saleh, C.
    Kim, L.
    Whalen-Browne, A.
    Chu, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S37 - S38
  • [48] CAPTAIN: Effects of smoking status on response to triple therapy in patients with inadequately controlled asthma on ICS/LABA
    Papi, Alberto
    Lee, Laurie
    Kerstjens, Huib
    Boulet, Louis-Philippe
    Zarankaite, Agne
    Pavord, Ian D.
    Brusselle, Guy
    Barnes, Neil
    Hanania, Nicola A.
    Pascoe, Steven
    Oppenheimer, John
    Pizzichini, Emilio
    Fowler, Andrew
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [49] Health Care Resource Utilization and Work Impairment for Asthma Patients Adherent to Medium- or High-Dosage ICS/LABA Fixed Combination Treatment: Findings From a US Real World Survey
    Davis, Jill R.
    Small, Mark
    Trudo, Frank J.
    Siddall, James
    Pike, James
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB59 - AB59
  • [50] Inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) combination vs. high doses of ICS: efficacy and safety in patients (pts) with uncontrolled occupational asthma
    Gashynova, Kateryna
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
12345